We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$178M |
| 2 |
LyondellBasell Industries
LYB
|
+$133M |
| 3 |
AT&T
T
|
+$124M |
| 4 |
Stanley Black & Decker
SWK
|
+$101M |
| 5 |
Pfizer
PFE
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$229M |
| 2 |
Gilead Sciences
GILD
|
+$164M |
| 3 |
Broadcom
AVGO
|
+$149M |
| 4 |
KeyCorp
KEY
|
+$145M |
| 5 |
Darden Restaurants
DRI
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.22% |
| 2 | Technology | 14.47% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 9.01% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Towne Bank
TOWN
$3.47B
| $38.4K | ﹤0.01% |
1,651
-801
| -33% | -$19.3K |
|
1702
BGC Group
BGC
$5.77B
| $38.3K | ﹤0.01% |
8,656
-7,577
| -47% | -$33.6K |
|
1703
James River Group Holdings
JRVR
$182M
| $38.2K | ﹤0.01% |
2,093
-1,833
| -47% | -$36.5K |
|
|
KYNB
1704
Kyntra Bio
KYNB
$31.5M
| $37.5K | ﹤0.01% |
556
-1,990
| -78% | -$823K |
|
1705
Nu Skin
NUS
$231M
| $37.4K | ﹤0.01% |
1,127
-10
| -0.9% | -$368 |
|
1706
Wynn Resorts
WYNN
$8.93B
| $37.3K | ﹤0.01% |
353
-28
| -7% | -$3K |
|
1707
Janus International
JBI
$607M
| $37.1K | ﹤0.01% |
3,476
-3,042
| -47% | -$28.5K |
|
|
WIRE
1708
DELISTED
Encore Wire Corp
WIRE
| $36.8K | ﹤0.01% |
198
-170
| -46% | -$28.8K |
|
1709
First Bancorp
FBP
$4.29B
| $36.6K | ﹤0.01% |
2,995
-36
| -1% | -$419 |
|
1710
Cavco Industries
CVCO
$4.12B
| $36.6K | ﹤0.01% |
124
-116
| -48% | -$33.3K |
|
1711
Sprout Social
SPT
$683M
| $36.4K | ﹤0.01% |
+789
| New | +$37.5K |
|
|
EVRI
1712
DELISTED
Everi Holdings
EVRI
| $36K | ﹤0.01% |
2,489
-2,061
| -45% | -$31.3K |
|
1713
First Guaranty Bancshares
FGBI
$139M
| $35.8K | ﹤0.01% |
3,186
-14
| -0.4% | -$185 |
|
1714
Clearway Energy Class C
CWEN
$6.14B
| $35.6K | ﹤0.01% |
+1,245
| New | +$37.6K |
|
1715
Comstock Resources
CRK
$4.2B
| $35.4K | ﹤0.01% |
3,055
-46,285
| -94% | -$482K |
|
1716
Diamondback Energy
FANG
$59.2B
| $34.8K | ﹤0.01% |
265
-82,972
| -100% | -$11.1M |
|
1717
Henry Schein
HSIC
$9.75B
| $34.5K | ﹤0.01% |
426
-66
| -13% | -$5.21K |
|
1718
Zions Bancorporation
ZION
$9.92B
| $34.5K | ﹤0.01% |
1,286
-72,848
| -98% | -$2.02M |
|
|
ZEUS
1719
DELISTED
Olympic Steel
ZEUS
| $34.3K | ﹤0.01% |
701
+418
| +148% | +$19.6K |
|
|
SLGC
1720
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $33.5K | ﹤0.01% |
+14,503
| New | +$40.9K |
|
1721
Patrick Industries
PATK
$2.27B
| $33.3K | ﹤0.01% |
624
-503
| -45% | -$23.7K |
|
|
UMH
1722
UMH Properties
UMH
$1.33B
| $33.2K | ﹤0.01% |
2,079
-1,863
| -47% | -$28.8K |
|
1723
Kratos Defense & Security Solutions
KTOS
$8.94B
| $32.8K | ﹤0.01% |
2,287
-1,242
| -35% | -$16.8K |
|
1724
Playtika
PLTK
$904M
| $31.7K | ﹤0.01% |
2,734
-68,077
| -96% | -$738K |
|
|
ITOS
1725
DELISTED
iTeos Therapeutics
ITOS
| $31.5K | ﹤0.01% |
2,376
-10,153
| -81% | -$145K |
|
Similar funds
Federated Hermes's Q2 2023 Portfolio in Review
As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
- Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
- Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
- Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
- Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
- Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
- Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.